SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is ...

Multiply Labs has developed a robotic biomanufacturing cluster that the company claims can reduce the cost of cell and gene therapy (CGT) manufacturing by 74%. The modular system achieves this by ...

Robotic biomanufacturing company Multiply Labs said it has made a significant advance toward its goal of scaling production of cell and gene therapies by using Nvidia’s open Isaac and GR00T robotics ...

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...

Multiply Labs Scales Robotics Driven Labs for Cell Therapy Biomanufacturing.